概率
用于荷兰单侧耳聋成人和儿童人工耳蜗成本-效用分析的概率参数数据集。
基本信息
资源简介
概率
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集，收录 1 个文件、合计 9.73 KB，主题涵盖 improve speech comprehension、health economic evaluation、clinical outcome parameters、probabilistic sensitivity analyses、bone conduction device，可用于统计建模、特征工程与队列分析，CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Probabilities.》。源站首次发布：2024-08-05。
【数据内容】
源站原始描述：Background Cochlear Implant (CI) has been shown to improve speech comprehension, sound localization and tinnitus in adults with Single-Sided-Deafness (SSD) compared to standard treatment currently available in the Dutch setting such as a CROS (Contralateral Routing of Signals) hearing device or a BCD (Bone Conduction Device). Also, for the pediatric population with SSD, CI has shown to be clinically meaningful. Because currently no information is available on the health economic effects of CI in…
【数据结构与技术规格】
文件数 1 个，合计 9.73 KB。Table 1.xls：application/vnd.ms-excel，9.73 KB。数据集 DOI：10.1371/journal.pone.0307881.t001。
【主题与分类】
源站学科分类：Medicine、Microbiology、Biotechnology、Cancer、Science Policy、Infectious Diseases。主题标签：improve speech comprehension、health economic evaluation、clinical outcome parameters、probabilistic sensitivity analyses、bone conduction device、costing data based、publicly available prices、markov cohort model、including productivity costs、health economic effects。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面：https://plos.figshare.com/articles/dataset/Probabilities_/26497113
使用许可：CC BY 4.0（https://creativecommons.org/licenses/by/4.0/）。
规范引用：van Lieshout, Chris; Abraham, Katharina; Smit, Adriana L.; Frederix, Geert W. J. (2024). Probabilities.. PLOS ONE. Dataset
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载，适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档，适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务（收技术服务费，非数据销售）
暂未开放当前数据集主要来源为 Kaggle 公开托管，完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取（Figshare）
- 源站标题：Probabilities.
- DOI：10.1371/journal.pone.0307881.t001
- 发布日期：2024-08-05
- 文件数：1 个
- 文件总体积：9.73 KB
- 源站页面：https://plos.figshare.com/articles/dataset/Probabilities_/26497113
命令行下载
curl -L -o "Table 1.xls" "https://ndownloader.figshare.com/files/48186891"
文件清单
Table 1.xls（9.73 KB）
文件总体积 9.73 KB（源站 API 实测）。
数据说明
Background
Cochlear Implant (CI) has been shown to improve speech comprehension, sound localization and tinnitus in adults with Single-Sided-Deafness (SSD) compared to standard treatment currently available in the Dutch setting such as a CROS (Contralateral Routing of Signals) hearing device or a BCD (Bone Conduction Device). Also, for the pediatric population with SSD, CI has shown to be clinically meaningful. Because currently no information is available on the health economic effects of CI in adults and children with SSD in the Netherlands, a cost-utility analysis was conducted.
Methods
We developed a Markov cohort model, for both the adult and pediatric SSD population, with three states: implant, no implant, and dead. CI was compared with the Bone Conduction Device (BCD) treatment, requiring surgery and no specific treatment. The time horizon of the model was lifelong, costs were discounted with 3% and effects with 1.5%. A societal perspective was taken, including productivity costs in the analysis, with costing data based on publicly available prices for the Netherlands. Values for clinical outcome parameters, i.e. hearing gain, and event probabilities were based on existing literature. Deterministic and probabilistic sensitivity analyses as well as scenario analyses were performed to outline uncertainty of individual and combined parameters.
Results
Mean per patient costs for CI in the adult population were €194,051 (95%-CrI €177,274 to €211,108) compared to the total costs of €185,310 (95%-CrI €182,367 to €194,142) for BCD resulting in a cost difference of €8,826 (95%-CrI -€5,020 to €18,252). Compared to no treatment, the cost difference was -€25,089 (95%-CrI -€31,678 to -€6,003). Adults who were treated with CI gained 18.41 (95%-CrI 18.07 to 18.75) quality adjusted life years (QALY) whereas BCD patients gained 15.81 QALYs (95%-CrI 15.53 to 16.10), a difference of 2.60 QALYs (95%-CrI 2.15 to 3.05). The Incremental Cost Effectiveness Ratio (ICER) for adults with CI was determined to be €3,494/QALY gained. Patient without treatment gained 13.46 QALY (95%-CrI 13.20 to 13.73), a difference of 4.95 (95%-CrI 4.87 to 5.01) resulting in CI dominating no treatment
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.1371/journal.pone.0307881.t001（source: https://plos.figshare.com/articles/dataset/Probabilities_/26497113）。
数据缺失？
依托陕西、四川两大基地，我们与超过十家三甲医院建立直接合作关系，覆盖合规授权、采集治理、专业标注、数据交付的全流程，为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务？立即联系我们获取专业方案。
